Informations: Ceci n’est pas la version la plus récente du modèle de données. Vous trouverez un aperçu de la version à gauche, sous Versions. Vous trouverez la version la plus actuelle ici.
Informations:
Erreur:
ID
30757
Description
Study part: Pharmacodynamics. A phase 1 single-masked, randomized (with respect to placebo), placebo-controlled, parallel-group, dose-rising study to evaluate the safety, tolerability and pharmacokinetics of repeat oral doses of GW786034 in elderly healthy volunteers. Trade Name: Votrient. Clinical Study ID: MD1103367.
Mots-clés
Versions (2)
- 19/06/2018 19/06/2018 -
- 20/09/2021 20/09/2021 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
19 juin 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Pharmacodynamics Pazopanib Macular Degeneration MD1103367
Similar models
Pharmacodynamics
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
PHARMACODYNAMICS - PD Prothrombin (PD FRAG)- 24 Hours
C0851347 (UMLS CUI-1)
C0033706 (UMLS CUI-2)
C0033706 (UMLS CUI-2)
CL Item
Day 7 (Day 7)
CL Item
Day 14 (Day 14)
date and time dosage
Item
Dosing date/time
datetime
C1717740 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
date and time sample collection
Item
Date/time of sample
datetime
C1717740 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,2])
Sample ID
Item
Sample ID
text
C1299222 (UMLS CUI [1])
Item Group
PHARMACODYNAMICS URINE -11-dehydrothromboxane B2 (PDU) Postdose at Day 7
C0851347 (UMLS CUI-1)
C0042036 (UMLS CUI-2)
C0044728 (UMLS CUI-3)
C0042036 (UMLS CUI-2)
C0044728 (UMLS CUI-3)
date and time dosage
Item
Dosing date/time
datetime
C1717740 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
date and time sample collection
Item
Date/time of sample
datetime
C1717740 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,2])
Sample ID
Item
Sample ID
text
C1299222 (UMLS CUI [1])
Item Group
PHARMACODYNAMICS - Bone Markers (PD BONE) 24 Hours at Day 14
C0851347 (UMLS CUI-1)
C0181734 (UMLS CUI-2)
C0181734 (UMLS CUI-2)
date and time dosage
Item
Dosing date/time
datetime
C1717740 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
date and time sample collection
Item
Date/time of sample
datetime
C1717740 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,2])
Sample ID
Item
Sample ID
text
C1299222 (UMLS CUI [1])
Item Group
PHARMACODYNAMICS - VEGF (PD VEGF) 24 Hours at Day 14
C0851347 (UMLS CUI-1)
C1256770 (UMLS CUI-2)
C1256770 (UMLS CUI-2)
date and time dosage
Item
Dosing date/time
datetime
C1717740 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
date and time sample collection
Item
Date/time of sample
datetime
C1717740 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,2])
Sample ID
Item
Sample ID
text
C1299222 (UMLS CUI [1])
Item Group
PHARMACODYNAMICS URINE -11-dehydrothromboxane B2 (PDU) Postdose at Day 15
C0851347 (UMLS CUI-1)
C0042036 (UMLS CUI-2)
C0044728 (UMLS CUI-3)
C0042036 (UMLS CUI-2)
C0044728 (UMLS CUI-3)
date and time sample collection
Item
Date/time of sample
datetime
C1717740 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,2])
Sample ID
Item
Sample ID
text
C1299222 (UMLS CUI [1])